ATC Group: N02AA05 Oxycodone

Position of N02AA05 in the ATC hierarchy

Level	Code	Title
1	N	Nervous system
2	N02	Analgesics
3	N02A	Opioids
4	N02AA	Natural opium alkaloids
5	N02AA05	Oxycodone

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Code	Route	Amount	Notes
ORAL	Oral	75 mg
PAREN	Parenteral	30 mg

Active ingredients in N02AA05

Active Ingredient
Oxycodone
Oxycodone is a full opioid agonist with no antagonist properties. It has an affinity for kappa, mu and delta opioid receptors in the brain and spinal cord. Oxycodone is similar to morphine in its action. The therapeutic effect is mainly analgesic, anxiolytic, antitussive and sedative.

Related product monographs

Document	Type	Information Source
LYNLOR Capsule, hard	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)
OXYACT Film-coated tablet	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)
OXYCONTIN Film-coated, extended release tablet	MPI, US: SPL/PLR	FDA, National Drug Code (US)
OXYNORM 10 mg/ml Solution for injection or infusion	MPI, EU: SmPC	Υπουργείο Υγείας (CY)
OXYNORM Capsule, hard	MPI, EU: SmPC	Υπουργείο Υγείας (CY)
OXYNORM Concentrate oral solution	MPI, EU: SmPC	Υπουργείο Υγείας (CY)

Medicines in this ATC group

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.